Overuse of unnecessary antibiotics

The overuse of unnecessary antibiotics has been the topic of the Monthly pulse we delivered to our panel members’ inboxes in July. In the UK it is estimated that 1.6 million unnecessary antibiotic prescriptions are issued each year and this issue is not exclusive to the UK.

Patients are used to visiting the GP whenever they suffer from illnesses like upper respiratory tract infections and often they expect to be prescribed antibiotic treatment, regardless of the efficacy.

Consequently, 70% of bacteria have now developed resistance to antibiotics as a result of overuse, which is now leading to the development of new strains of antibiotic-resistant bacteria.

We asked our community where the responsibility of raising awareness about antibiotic overuse lies – with the prescribing physician, or with healthcare institutions and/or governmental bodies?

The survey was conducted amongst 15,875 M3 members in Europe (Uk, France, Italy, Spain and Germany), Canada and USA.

The results in Canada, Europe and USA are similar. More than 90% in from the threes respondent groups agree that is the responsibility of the physician to reduce unnecessary antibiotic use.

In Europe, 93% of the healthcare professionals surveyed in the UK, Germany, France, Spain, and Italy think that it is the responsibility of the physician to reduce unnecessary antibiotic use. Spanish and Italian respondents, at 95%, are the most supportive of this view. Conversely, with 85% in favour, French doctors are the least supportive.

By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to give your opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.

overuse of unnecessary antibiotics


overuse of unnecessary antibiotics


  1. Antimicrobial resistance happens when microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarials, and anthelmintics). Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.Antimicrobial resistance increases the cost of health care with lengthier stays in hospitals and more intensive care required

    1. Thank you very much for your comment, doctor. Very interesting insights! The M3 Global Research Team.

  2. Es una realidad y si el médico no prescribe antibióticos es responsable de que luego pueda haber neumonías,sinusitis,bronquitis aunque no haya ni fiebre ni adenopatias

    1. Muchas gracias por su comentario, Dr. Pérez. Valoramos mucho los comentarios de profesionales de la salud como usted. Le animamos a que siga visitando nuestro blog. El equipo de M3 Global Research.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.